ＩＦＮ　γ

• 種: ヒト
• 分析対象: IFN ガンマ 
• 製品タイプ: 発色法 ELISA
• 製品フォーマット: キット
• パッケージサイズ: 1 or 5 プレートキット
• 定量レンジ: 25.6 - 1,000 pg/ml
• 感度: < 2 pg/ml
• 定量に必要な総時間: 3 hours
• 試料の容量: 50 µl/well
• 試料タイプ: 血清、血漿(EDTA、クエン酸ナトリウム、ヘパリン)、培養細胞上清、尿
• 検出波長: A_{450 nm} minus A_{550 nm} *
  
  *マイクロプレートによる吸光を補正するために、A_550nm値を減ずることを勧めるが、必ずしも必要ではない

1. Ahuja, S.S., et al. (1998) Human dendritic cell (DC)-based anti-infective therapy: engineering DCs to secrete functional IFN-gamma and IL-12. J. Immunol. 161, 868-876.
2. Cesano, A., et al. (1998). Role of CD38 and its ligand in the regulation of MHC-nonrestricted cytotoxic T cells. J. Immunol. 160, 1106-1115.
3. Gollob, J.A., et al. (1998). Characterization of a novel subset of CD8(+) T cells that expands in patients receiving interleukin-12. J. Clin. Invest. 102, 561-575.
4. Guo, F.H., et al. (1997). Interferon gamma and interleukin 4 stimulate prolonged expression of inducible nitric oxide synthase in human airway epithelium through synthesis of soluble mediators. J. Clin. Invest. 100, 829-838.
5. Khatri, V.P., et al. (1998). Ultra low dose interleukin-2 therapy promotes a type 1 cytokine profile in vivo in patients with AIDS and AIDS-associated malignancies. J. Clin. Invest. 101, 1373-1378.
6. Lee, K. et al. (1998). Functional dissociation between local and systemic immune response during anti-melanoma peptide vaccination. J. Immunol. 161, 4183-4194.
7. Tuting, T., et al. (1998). Autologous human monocyte-derived dendritic cells genetically modified to express melanoma antigens elicit primary cytotoxic T cell responses in vitro: enhancement by cotransfection of genes encoding the Th1-biasing cytokines IL-12 and IFN-alpha. J. Immunol. 160, 1139-1147.
8. Voss, S.D., et al. (1998). Participation of the CD94 receptor complex in costimulation of human natural killer cells. J. Immunol. 160, 1618-1626.